Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets

Publication Date	December 2008
Publisher	Frost & Sullivan
Product Type	Report
Pages	96
ISBN Number	not applicable
Product Code	FRS01026

Buy this product or for assistance call +44 20 7060 7474

PDF £3,605.00$5997 | €4035

FAX Order above formats by FAX

Summary

This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifying critical road blocks in the growth of the Sci-BI market. A step by step analysis of the R&D cost distribution in pharma/biotech was carried out together with a competitive landscape analysis of the different players in this niche market segment.

Content

1 Introduction
- Title Page
- Disclaimer
- Certification
- Table of Contents
- Notes on Methodology
2 Market Introduction and Segmentation
- Introduction
- Segmentation
3 Major Global Trends in Healthcare
- Major Global Healthcare Trends
4 Current Industry Trends in Sci-Bi
- Current Industry Trends in Sci-BI
5 Sci-Bi Drivers and Restraints
- Overall Market Drivers and Restraints
- Sci-BI Drivers
  - Drivers for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015
- Sci-BI Restraints
  - Restraints for Sci-BI in Pharma/Biotech Ranked in Order of Impact 2008-2015
6 Sci-Bi Opportunity Analysis
- Opportunity Analysis - Major Areas of Convergence
- Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management
7 Pharma/Biotech R&d & Sci-Bi
- The ROI Challenge for Pharma
- Pharmaceutical R&D Expenditure
- End to End Sci-BI Services
8 Sci-Bi Markets Competitive Landscape
- Sci-BI Markets: Competitive Landscape
  - Competitive Analysis by Company
9 Challenges and Conclusions
10 about Frost & Sullivan